secwatch / observer
8-K filed October 5, 2023, 7:59 PM ET ticker MYGN CIK 0000899923
leadership confidence high sentiment neutral materiality 0.60

Myriad Genetics COO Nicole Lambert to step down Oct 31; remains consultant through Mar 2024

MYRIAD GENETICS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Nicole Lambert

Chief Operating Officer
MYGN · MYRIAD GENETICS INC
Effective
2023-10-31
Filed
October 5, 2023, 7:59 PM ET
On October 4, 2023, Nicole Lambert, Chief Operating Officer of Myriad Genetics, Inc. (the “Company”) and the Company mutually reached an agreement that Ms. Lambert would step down from such position, effective October 31, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nicole Lambert departed as Chief Operating Officer at MYRIAD GENETICS INC.

Action
stepped down
Role
Chief Operating Officer
Exact text from the filing
On October 4, 2023, Nicole Lambert, Chief Operating Officer of Myriad Genetics, Inc. (the “Company”) and the Company mutually reached an agreement that Ms. Lambert would step down from such position, effective October 31, 2023
View on SEC.gov

MYRIAD GENETICS INC filing history →

Source: SEC EDGAR
accession 0000899923-23-000064
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.